LONDON - In a move to strengthen its presence in the North America healthcare sector, Endava, a leading technology services company, announced its plans to acquire GalaxE Group, Inc. (GalaxE), a global IT and business solutions provider based in New Jersey, United States. The acquisition, which involves a 100% ownership takeover, is set to propel Endava’s capabilities in digital transformation for Fortune 500 companies.
GalaxE, founded by Tim Bryan over 30 years ago, has garnered a reputation for driving digital transformation initiatives in the healthcare industry. With a focus on Fortune 500 companies, GalaxE has utilized its expertise to streamline operations and enhance efficiency for its clients. By acquiring GalaxE, Endava aims to strengthen its foothold in the North America healthcare sector and accelerate its growth in this highly competitive market.
This acquisition provides Endava with a unique advantage by leveraging GalaxE’s expertise in healthcare delivery from India. India’s global reputation as a hub for technology and software solutions has positioned it as a key player in the IT and business solutions industry. By tapping into India’s resources, Endava can benefit from cost-effective operations without compromising on quality.
The healthcare industry, especially in North America, has been undergoing a massive digital transformation in recent years. The COVID-19 pandemic has further accelerated the need for innovative technology solutions to address the challenges faced by the healthcare sector. With this acquisition, Endava is well-positioned to offer comprehensive digital transformation solutions to its healthcare clients that enhance patient care, improve operational efficiency, and drive overall growth and success.
The combination of Endava’s world-class engineering capabilities, industry expertise, and people-centric mindset, along with GalaxE’s extensive experience and track record, highlights the significant potential of this acquisition. Endava’s commitment to delivering exceptional results to its clients aligns seamlessly with GalaxE’s approach, making this a strategic move for both companies.
The successful completion of this acquisition will not only solidify Endava’s position in the North America healthcare industry but also open up new avenues for expansion and growth. By capitalizing on the expertise and resources of both Endava and GalaxE, the merged entity will be better equipped to address the evolving needs of the healthcare sector and provide innovative solutions at scale.
Comments